Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial.
about
Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial.Evaluating the benefits of home-based management of atrial fibrillation: current perspectivesCatheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysisHeart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationEHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Lone Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persists Despite Successful Catheter AblationRelation of overweight and symptomatic atrial fibrillation: A case report.Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation.The challenges of real-world implementation of web-based shared care software: the HopSCOTCH Shared-Care Obesity Trial in Children.B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study.[Interventional treatment for paroxysmal atrial fibrillation : which is the optimal ablation approach?].Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.Relationship between epicardial adipose tissue volume and atrial fibrillation : A systematic review and meta-analysis.Whole Blood Gene Expression Differentiates between Atrial Fibrillation and Sinus Rhythm after CardioversionAssociations of obesity and body fat distribution with incident atrial fibrillation in the biracial health aging and body composition cohort of older adults.Relation of Body Mass Index With Adverse Outcomes Among Patients With Atrial Fibrillation: A Meta-Analysis and Systematic ReviewDeterminants of Left Atrial Volume in Patients with Atrial Fibrillation.Inflammation as a Mediator of the Association Between Race and Atrial Fibrillation: Results from the Health, Aging, and Body Composition Study.Findings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion.Cardiovascular exercise and burden of arrhythmia in patients with atrial fibrillation - A randomized controlled trial.Tools for Successful Weight Management in Primary CareOxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation: An Update.Endurance Sport Activity and Risk of Atrial Fibrillation - Epidemiology, Proposed Mechanisms and Management.The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysisCarotid Intima-Media Thickness and Arterial Stiffness and the Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study, Multi-Ethnic Study of Atherosclerosis (MESA), and the Rotterdam StudyThe Future of Arrhythmias and ElectrophysiologyRisk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation.Atrial Fibrillation, Cognitive Decline And Dementia.Electrophysiology Updates in Adult Congenital Heart Disease.Quality of life perception in type 2 diabetes.Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation.Total adiponectin is inversely associated with platelet activation and CHA₂DS₂-VASc score in anticoagulated patients with atrial fibrillation.Catheter ablation in patients with persistent atrial fibrillationManagement of Patients with Atrial Fibrillation: Focus on Treatment Options.Decade in review--arrhythmias: Cardiac fibrillation--challenges and evolving solutions.The importance of sleep-disordered breathing in cardiovascular disease.The role of obesity in atrial fibrillation.Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications.
P2860
Q27334353-A51BCC9D-15CC-4CC1-9E0C-1F0ED4CE9E47Q28079137-F64F7556-59CA-46C9-935F-B6F14263077DQ28088371-75848F8F-A3DA-4233-BFBD-FCADB2577DABQ30238784-02091263-48EB-4C3A-963E-C2AEEE2DF567Q30375302-131F2CFE-77D2-4F1D-8997-199A0AABF2D8Q30819519-DCF6DF48-9AF0-4EB7-AB76-480039C28369Q33643412-E31484F8-F79A-4977-AF8C-E5C962BA40B3Q33844478-45B5D750-D7B8-4D26-AB91-35241A1BEC98Q33971532-FF3CCE78-AC4C-480F-8237-E2F34123B53DQ34342621-FCC0D1BE-0A80-42E4-8FA0-D5B400850650Q34375466-82B55DB3-42D7-400C-AFA2-9B1574222BCDQ35208862-41CD055B-FF6F-4DAE-892F-46140FFDCF60Q35542264-E96DAE33-0AD5-4DB1-A2A6-26B5DCB384A5Q35585789-A40DC593-42B9-4F60-886C-BB4217985696Q35867367-3F5176A7-AD55-4296-BCA0-5E23EA606F74Q36058896-9CBF12D3-3866-4A49-9CC5-095D7DDB2BC3Q36074807-B474C936-8C16-4F79-B1B6-D3CAAD00726CQ36129218-71961CE9-AF78-4691-9CCC-175C0C262764Q36152831-D49CCA5A-0815-4E99-8C81-8ED771316318Q36185363-44F0B28D-15DD-412D-A3BD-4187FF46879FQ36287783-BA266BD7-181D-4A89-BBA8-35E524E6345BQ36288627-5E012A95-ABDB-41F2-ADDA-B187C01AB9BDQ36338832-FA9E4567-3880-46CD-89D5-454796CDE839Q36359544-2D0CF591-F31D-4331-BB9C-4B6E78F6592EQ36458821-5503931E-CA6B-4037-892F-BBE5CFBB8F56Q36650575-47FD8575-9FA2-4B53-B849-AA42D9DC9E76Q36956679-025435DF-7CF9-4390-9FA8-0CA7906FD7E3Q37058592-9AA85BF8-D862-4FE2-B544-7E363DA938CEQ37118899-50F03EC8-994F-4795-881F-21585ACFD991Q37183467-9B4E3EA3-C087-427E-B21A-197D63AB7F58Q37344566-37876044-86B1-4EE7-B7E4-50856DEAE5A0Q37432575-B1E6DF3B-9981-4466-97CA-191B604CD540Q37496071-21891187-E3A6-44B8-835D-58F1D8A0E50AQ37639726-875764AA-1E91-4966-92D3-8186E4F11152Q37704983-0C50F19F-8F13-44EC-8022-2785E8EF9CD2Q37723881-D99EC745-4E42-477E-818D-3D069BC7A9C8Q38247017-188E8D69-5A0F-42A1-80C2-9A91F047C833Q38436072-0D740349-B3E3-4162-AAEB-1F9221421172Q38586946-4C1F2772-3F34-4218-B370-D55CDA82A9EEQ38636457-A3CB15A0-8041-4845-A766-1884C8B6FEE4
P2860
Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effect of weight reduction and ...... : a randomized clinical trial.
@en
type
label
Effect of weight reduction and ...... : a randomized clinical trial.
@en
prefLabel
Effect of weight reduction and ...... : a randomized clinical trial.
@en
P2093
P50
P356
P1476
Effect of weight reduction and ...... n: a randomized clinical trial
@en
P2093
Anthony G Brooks
Bobak Bahrami
Darryl P Leong
Gary A Wittert
Hany S Abed
Jonathan M Kalman
Masoumeh G Shirazi
Nicholas A Antic
P304
P356
10.1001/JAMA.2013.280521
P407
P577
2013-11-01T00:00:00Z